Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Leblond

Showing results (81-90 of 167) with videos related to

Pageof 17
Sort By:
Leukemia|February 20, 1999
Leukemic CD3+ LGL share functional properties with their CD8+ CD57+ cell counterpart expanded after BMTL Mollet, B Fautrel, V Leblond, et al.
Journal of the American Society of Nephrology : JASN|December 1, 1995
Evaluation of renal function in 60 long-term survivors of bone marrow transplantationV Leblond, L Sutton, C Jacquiaud, et al.
Bone Marrow Transplantation|November 1, 1992
Peripheral blood stem cell collection and autografting in high risk lymphomasF Dreyfus, V Leblond, C Belanger, et al.
Bone Marrow Transplantation|November 12, 2014
Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemiaN Jacque, S Nguyen, J-L Golmard, et al.
Annals of the Rheumatic Diseases|April 28, 2000
Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemiaE Aslangul-Castier, T Papo, Z Amoura, et al.
The American Journal of Pathology|May 4, 2000
Expression of p16/INK4a in posttransplantation lymphoproliferative disordersA Martin, F Baran-Marzak, S El Mansouri, et al.
Blood|May 1, 1991
Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemiaE Archimbaud, V Leblond, M Michallet, et al.
Scandinavian Journal of Rheumatology|October 1, 2005
AL cardiac amyloidosis and arterial thromboembolic eventsP Hausfater, N Costedoat-Chalumeau, Z Amoura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?V Leblond, F Davi, F Charlotte, et al.
The Pharmacogenomics Journal|October 17, 2012
Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancyN Simon, A Marsot, E Villard, et al.
Pageof 17

Showing results (81-90 of 167) with videos related to

Sort By:
Pageof 17
Leukemia|February 20, 1999
Leukemic CD3+ LGL share functional properties with their CD8+ CD57+ cell counterpart expanded after BMTL Mollet, B Fautrel, V Leblond, et al.
Journal of the American Society of Nephrology : JASN|December 1, 1995
Evaluation of renal function in 60 long-term survivors of bone marrow transplantationV Leblond, L Sutton, C Jacquiaud, et al.
Bone Marrow Transplantation|November 1, 1992
Peripheral blood stem cell collection and autografting in high risk lymphomasF Dreyfus, V Leblond, C Belanger, et al.
Bone Marrow Transplantation|November 12, 2014
Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemiaN Jacque, S Nguyen, J-L Golmard, et al.
Annals of the Rheumatic Diseases|April 28, 2000
Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemiaE Aslangul-Castier, T Papo, Z Amoura, et al.
The American Journal of Pathology|May 4, 2000
Expression of p16/INK4a in posttransplantation lymphoproliferative disordersA Martin, F Baran-Marzak, S El Mansouri, et al.
Blood|May 1, 1991
Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemiaE Archimbaud, V Leblond, M Michallet, et al.
Scandinavian Journal of Rheumatology|October 1, 2005
AL cardiac amyloidosis and arterial thromboembolic eventsP Hausfater, N Costedoat-Chalumeau, Z Amoura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?V Leblond, F Davi, F Charlotte, et al.
The Pharmacogenomics Journal|October 17, 2012
Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancyN Simon, A Marsot, E Villard, et al.
Pageof 17